• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

Comprehensive Overview of Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester (CAS No. 2019349-67-6)

The compound Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester, identified by its CAS No. 2019349-67-6, is a specialized organic molecule with significant applications in pharmaceutical and agrochemical research. This ester derivative of carbamic acid features a unique structural framework, including a 3-methylcyclohexyl moiety and a tert-butyl ester group, which contribute to its stability and reactivity. Researchers are increasingly interested in this compound due to its potential as an intermediate in the synthesis of bioactive molecules, particularly in the development of novel enzyme inhibitors and prodrugs.

In recent years, the demand for high-purity chemical intermediates like Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester has surged, driven by advancements in drug discovery and green chemistry. The compound's CAS No. 2019349-67-6 is frequently searched in scientific databases, reflecting its relevance in medicinal chemistry and process optimization. Its structural versatility allows for modifications that can enhance bioavailability or target-specific interactions, making it a valuable tool for structure-activity relationship (SAR) studies.

One of the key advantages of this compound lies in its tert-butyl ester group, which offers protecting group functionality in synthetic pathways. This feature is particularly useful in peptide synthesis and the development of small-molecule therapeutics. Additionally, the 3-methylcyclohexyl segment introduces steric and electronic effects that can influence the compound's binding affinity to biological targets. Such properties align with current trends in precision medicine and personalized therapeutics, where tailored molecular designs are critical.

The synthesis of Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester typically involves multi-step organic reactions, including amidation and esterification processes. Researchers often optimize these steps to improve yield and purity, addressing common challenges like byproduct formation and scalability. The compound's CAS No. 2019349-67-6 is a crucial identifier for sourcing reliable reference standards, especially in quality control and regulatory compliance for pharmaceutical applications.

Beyond its synthetic utility, Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester has garnered attention in computational chemistry and molecular modeling. Its well-defined structure enables accurate docking simulations and pharmacophore mapping, which are essential for virtual screening campaigns. This aligns with the growing adoption of AI-driven drug design, where CAS No. 2019349-67-6 serves as a benchmark for validating predictive algorithms.

Environmental and safety considerations are also paramount when working with this compound. While it is not classified as hazardous, proper handling protocols are recommended to ensure occupational health and waste management compliance. The compound's stability under various storage conditions makes it suitable for long-term research projects, further enhancing its appeal in academic and industrial laboratories.

In summary, Carbamic acid, N-[2-(3-methylcyclohexyl)-2-oxoethyl]-, 1,1-dimethylethyl ester (CAS No. 2019349-67-6) represents a versatile and scientifically valuable compound. Its applications span drug development, chemical synthesis, and computational research, reflecting its alignment with contemporary scientific priorities. As the demand for specialty chemicals continues to rise, this compound is poised to play a pivotal role in advancing innovative therapeutic solutions and sustainable chemistry practices.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)